BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang XD, Fan Y, Zhang H, Wang P, Yuan JP, Li MJ, Zhan XY. Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World J Gastroenterol 2008; 14(18): 2888-2893 [PMID: 18473416 DOI: 10.3748/wjg.14.2888]
URL: https://www.wjgnet.com/1007-9327/full/v14/i18/2888.htm
Number Citing Articles
1
Scott McNear, Stephen A. Harrison. Review: Current status of therapy in nonalcoholic fatty liver diseaseTherapeutic Advances in Gastroenterology 2009; 2(1): 29 doi: 10.1177/1756283X08100327
2
Giovanni Tarantino. Gut Microbiome, Obesity-Related Comorbidities, and Low-Grade Chronic InflammationThe Journal of Clinical Endocrinology & Metabolism 2014; 99(7): 2343 doi: 10.1210/jc.2014-2074
3
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
4
Shira Zelber-Sagi, Vlad Ratziu, Izabel Zvibel, Ilana Goldiner, Laurie Blendis, Gilles Morali, Zamir Halpern, Ran Oren. The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injuryEuropean Journal of Gastroenterology & Hepatology 2012; 24(3): 262 doi: 10.1097/MEG.0b013e32834f15dd
5
Chenyang Zhang, Bin Zhang, Xuelian Zhang, Min Wang, Xiaobo Sun, Guibo Sun. Panax notoginsengSaponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism ModulationJournal of the American Heart Association 2022; 11(4) doi: 10.1161/JAHA.121.023540
6
Sandra Milić, Davorka Lulić, Davor Štimac. Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentationsWorld Journal of Gastroenterology 2014; 20(28): 9330-9337 doi: 10.3748/wjg.v20.i28.9330
7
Everton Cazzo, José Carlos Pareja, Elinton Adami Chaim. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive reviewSao Paulo Medical Journal 2017; 135(3): 277 doi: 10.1590/1516-3180.2016.0306311216
8
S. Petta, C. Muratore, A. Craxì. Non-alcoholic fatty liver disease pathogenesis: The present and the futureDigestive and Liver Disease 2009; 41(9): 615 doi: 10.1016/j.dld.2009.01.004
9
Lucia De la Cruz-Color, Jose Alfredo Dominguez-Rosales, Montserrat Maldonado-González, Bertha Ruíz-Madrigal, Martha P. Sánchez Muñoz, Vianney Alejandrina Zaragoza-Guerra, Victor H. Espinoza-Padilla, Elizabeth del C. Ruelas-Cinco, Sandra M. Ramírez-Meza, José R. Torres Baranda, María del R. González-Gutiérrez, Zamira Helena Hernandez Nazara. Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in HumansInternational Journal of Molecular Sciences 2024; 25(12): 6420 doi: 10.3390/ijms25126420
10
Yoichi Asaoka, Shuji Terai, Isao Sakaida, Hiroshi Nishina. The expanding role of fish models in understanding non-alcoholic fatty liver diseaseDisease Models & Mechanisms 2013;  doi: 10.1242/dmm.011981
11
I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanismsProceedings of the Nutrition Society 2016; 75(1): 47 doi: 10.1017/S0029665115004218
12
Yan Chen, Wenkan Liu, Jun Ma, Yaorong Wang, Hai Huang. Comprehensive physiological and transcriptomic analysis revealing the responses of hybrid grouper (Epinephelus fuscoguttatus♀ × E. lanceolatus♂) to the replacement of fish meal with soy protein concentrateFish Physiology and Biochemistry 2020; 46(6): 2037 doi: 10.1007/s10695-020-00851-3
13
Pierre-Antoine Soret, Julie Magusto, Chantal Housset, Jérémie Gautheron. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical AppraisalJournal of Clinical Medicine 2020; 10(1): 36 doi: 10.3390/jcm10010036
14
Giovanni Tarantino, Vincenzo Citro, Mauro Cataldi. Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?Viruses 2021; 13(7): 1285 doi: 10.3390/v13071285
15
Eunha Chang, Jae Seung Chang, In Deok Kong, Soon Koo Baik, Moon Young Kim, Kyu-Sang Park. Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver DiseaseGut and Liver 2022; 16(2): 171 doi: 10.5009/gnl210106
16
Maria Petrescu, Sonia Irina Vlaicu, Lorena Ciumărnean, Mircea Vasile Milaciu, Codruța Mărginean, Mira Florea, Ștefan Cristian Vesa, Monica Popa. Chronic Inflammation—A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose TissueMedicina 2022; 58(5): 641 doi: 10.3390/medicina58050641
17
J. K. Dowman, J.W. Tomlinson, P.N. Newsome. Pathogenesis of non-alcoholic fatty liver diseaseQJM 2010; 103(2): 71 doi: 10.1093/qjmed/hcp158
18
Ancha Baranova, Aybike Birerdinc, Zobair M. Younossi. Adipose Tissue and Adipokines in Health and Disease2014; : 249 doi: 10.1007/978-1-62703-770-9_17
19
María Eugenia Inzaugarat, Elena De Matteo, Placida Baz, Diego Lucero, Cecilia Claudia García, Esteban Gonzalez Ballerga, Jorge Daruich, Juan Antonio Sorda, Miriam Ruth Wald, Alejandra Claudia Cherñavsky, Vida A. Dennis. New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humansPLOS ONE 2017; 12(3): e0172900 doi: 10.1371/journal.pone.0172900
20
Israt Ara Hossain, Salima Akter, Mohammad Khalilur Rahman, Liaquat Ali, Harpal Singh Randeva. Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic SubjectsPLOS ONE 2015; 10(11): e0142165 doi: 10.1371/journal.pone.0142165
21
Julian Schwärzler, Felix Grabherr, Christoph Grander, Timon E. Adolph, Herbert Tilg. The pathophysiology of MASLD: an immunometabolic perspectiveExpert Review of Clinical Immunology 2024; 20(4): 375 doi: 10.1080/1744666X.2023.2294046
22
Hyun-Seuk Moon, Maria Dalamaga, Sang-Yong Kim, Stergios A. Polyzos, Ole-Petter Hamnvik, Faidon Magkos, Jason Paruthi, Christos S. Mantzoros. Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic IndividualsEndocrine Reviews 2013; 34(3): 377 doi: 10.1210/er.2012-1053
23
Yuexia Zhang, Shanshan Ge, Zhenhua Yang, Zhongping Li, Xiaojuan Gong, Quanxi Zhang, Wenjuan Dong, Chuan Dong. Disturbance of di-(2-ethylhexyl) phthalate in hepatic lipid metabolism in rats fed with high fat dietFood and Chemical Toxicology 2020; 146: 111848 doi: 10.1016/j.fct.2020.111848
24
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
25
Adel Hammoutene, Pierre-Emmanuel Rautou. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver diseaseJournal of Hepatology 2019; 70(6): 1278 doi: 10.1016/j.jhep.2019.02.012
26
Roya Navekar, Maryam Rafraf, Aida Ghaffari, Mohammad Asghari-Jafarabadi, Manouchehr Khoshbaten. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver DiseasesJournal of the American College of Nutrition 2017; 36(4): 261 doi: 10.1080/07315724.2016.1267597
27
Yu Wang, Mingyan Zhou, Karen S. L. Lam, Aimin Xu. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implicationsArquivos Brasileiros de Endocrinologia & Metabologia 2009; 53(2): 201 doi: 10.1590/S0004-27302009000200012
28
Shankar Baskar, Simone Jhaveri, Naim Alkhouri. Cardiovascular risk in pediatric nonalcoholic fatty liver disease: recent advancesClinical Lipidology 2015; 10(4): 351 doi: 10.2217/clp.15.26
29
Isabella Reccia, Jayant Kumar, Cherif Akladios, Francesco Virdis, Madhava Pai, Nagy Habib, Duncan Spalding. Non-alcoholic fatty liver disease: A sign of systemic diseaseMetabolism 2017; 72: 94 doi: 10.1016/j.metabol.2017.04.011
30
Hessah Al‑Muzafar, Kamal Amin. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistinExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6563
31
T.O. Elufioye, O.I. Alatise, F.A. Fakoya, J.M. Agbedahunsi, P.J. Houghton. Toxicity studies of Tithonia diversifolia A. Gray (Asteraceae) in ratsJournal of Ethnopharmacology 2009; 122(2): 410 doi: 10.1016/j.jep.2008.12.007
32
Christina-Maria Flessa, Narjes Nasiri-Ansari, Ioannis Kyrou, Bianca M. Leca, Maria Lianou, Antonios Chatzigeorgiou, Gregory Kaltsas, Eva Kassi, Harpal S. Randeva. Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) ResearchInternational Journal of Molecular Sciences 2022; 23(24): 15791 doi: 10.3390/ijms232415791
33
Laureane Nunes Masi, Amanda Roque Martins, Amanda Rabello Crisma, Cátia Lira do Amaral, Mariana Rodrigues Davanso, Tamires Duarte Afonso Serdan, Roberta Dourado Cavalcante da Cunha de Sá, Maysa Mariana Cruz, Maria Isabel Cardoso Alonso-Vale, Rosângela Pavan Torres, Jorge Mancini-Filho, Joice Naiara Bertaglia Pereira, Marta Maria da Silva Righetti, Edson Aparecido Liberti, Sandro Massao Hirabara, Rui Curi. Combination of a high-fat diet with sweetened condensed milk exacerbates inflammation and insulin resistance induced by each separately in miceScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04308-1
34
Ju Ri Ham, Hae-In Lee, Ra-Yeong Choi, Mi-Ok Sim, Kwon-Il Seo, Mi-Kyung Lee. Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese miceFood & Function 2016; 7(2): 689 doi: 10.1039/C5FO01329A
35
María Gabriela Delgado, Jordi Gracia-Sancho, Giusi Marrone, Aina Rodríguez-Vilarrupla, Ramon Deulofeu, Juan G. Abraldes, Jaume Bosch, Juan Carlos García-Pagán. Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 305(7): G496 doi: 10.1152/ajpgi.00336.2012
36
Hironori Mizutani, Satoshi Fukushima, Shinichi Masuguchi, Junji Yamashita, Azusa Miyashita, Satoshi Nakahara, Jun Aoi, Yuji Inoue, Masatoshi Jinnin, Hironobu Ihn. Serum levels of leptin receptor in patients with malignant melanoma as a new tumor markerExperimental Dermatology 2013; 22(11): 748 doi: 10.1111/exd.12238
37
Mariana V. Machado, João Coutinho, Fátima Carepa, Adília Costa, Helena Proença, Helena Cortez-Pinto. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2012; 24(10): 1166 doi: 10.1097/MEG.0b013e32835609b0
38
Mohammad Ariya, Farbod Koohpayeh, Alireza Ghaemi, Saeed Osati, Sayed Hossain Davoodi, Jalaledin Mirzay Razzaz, Gholamali Javedan, Elham Ehrampoush, Reza Homayounfar, Gianfranco D. Alpini. Assessment of the association between body composition and risk of non-alcoholic fatty liverPLOS ONE 2021; 16(4): e0249223 doi: 10.1371/journal.pone.0249223
39
Stergios A. Polyzos, Konstantinos N. Aronis, Jannis Kountouras, Dimitrios D. Raptis, Maria F. Vasiloglou, Christos S. Mantzoros. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysisDiabetologia 2016; 59(1): 30 doi: 10.1007/s00125-015-3769-3
40
Li Zhang, Haiyan Song, Yingli Ge, Guang Ji, Zemin Yao, Julie A. Chowen. Temporal Relationship between Diet-Induced Steatosis and Onset of Insulin/Leptin Resistance in Male Wistar RatsPLOS ONE 2015; 10(2): e0117008 doi: 10.1371/journal.pone.0117008
41
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal diseaseAmerican Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
42
Richard Parker. The role of adipose tissue in fatty liver diseasesLiver Research 2018; 2(1): 35 doi: 10.1016/j.livres.2018.02.002
43
Shadi S. Yarandi, Gautam Hebbar, Cary G. Sauer, Conrad R. Cole, Thomas R. Ziegler. Diverse roles of leptin in the gastrointestinal tract: Modulation of motility, absorption, growth, and inflammationNutrition 2011; 27(3): 269 doi: 10.1016/j.nut.2010.07.004
44
Hao Zheng, Shilin Li, Liang Ma, Ling Cheng, Chongyang Deng, Zhizhi Chen, Caifeng Xie, Mingli Xiang, Wei Jiang, Lijuan Chen. A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistanceEuropean Journal of Pharmacology 2011; 659(2-3): 244 doi: 10.1016/j.ejphar.2011.03.033
45
Margalida Monserrat-Mesquida, Cristina Bouzas, Catalina M. Mascaró, Silvia Tejada, Antoni Sureda. Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)Fermentation 2023; 9(4): 395 doi: 10.3390/fermentation9040395
46
Huong Thi Nguyen, Mingkun Gu, Pia Werlinger, Joo-Hyung Cho, Jinhua Cheng, Joo-Won Suh. Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut MicrobiotaInternational Journal of Molecular Sciences 2022; 23(21): 13436 doi: 10.3390/ijms232113436
47
Xiao-Min Xin, Mu-Xiao Zhong, Gong-Li Yang, Yao Peng, Ya-Li Zhang, Wei Zhu. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cellsWorld Journal of Gastroenterology 2014; 20(42): 15727-15735 doi: 10.3748/wjg.v20.i42.15727
48
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Leptin in nonalcoholic fatty liver disease: A narrative reviewMetabolism 2015; 64(1): 60 doi: 10.1016/j.metabol.2014.10.012
49
Jun Zhao, Matthew W. Lawless. Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancerCytokine 2013; 64(3): 626 doi: 10.1016/j.cyto.2013.09.009
50
Mithun Sharma, Shasikala Mitnala, Ravi K. Vishnubhotla, Rathin Mukherjee, Duvvur N. Reddy, Padaki N. Rao. The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic SteatohepatitisJournal of Clinical and Experimental Hepatology 2015; 5(2): 147 doi: 10.1016/j.jceh.2015.02.002
51
Andrea Bell, Soheila Korourian, Huawei Zeng, Joshua Phelps, Reza Hakkak. A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat modelFood & Function 2017; 8(3): 1293 doi: 10.1039/C6FO01772J
52
Farnaz Farsi, Majid Mohammadshahi, Pezhman Alavinejad, Afshin Rezazadeh, Mehdi Zarei, Kambiz Ahmadi Engali. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical TrialJournal of the American College of Nutrition 2016; 35(4): 346 doi: 10.1080/07315724.2015.1021057
53
Ramya Bhat S, Indumathi Shankaraiah. STUDY OF PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS ASSOCIATION WITH TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE HOSPITALJournal of Evolution of Medical and Dental Sciences 2019; 8(23): 1830 doi: 10.14260/jemds/2019/402
54
Min‐Hsiung Pan, Ching‐Shu Lai, Mei‐Ling Tsai, Chi‐Tang Ho. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compoundsMolecular Nutrition & Food Research 2014; 58(1): 147 doi: 10.1002/mnfr.201300522
55
Sanjali Charles, Yutong Liu, Wandia Kimita, Juyeon Ko, Sakina H. Bharmal, Maxim S. Petrov. Effect of d-β-hydroxybutyrate-(R)-1,3 butanediol on plasma levels of asprosin and leptin: results from a randomised controlled trialFood & Function 2023; 14(2): 759 doi: 10.1039/D2FO02405E
56
Masakazu Umezawa, Masayuki Nakamura, Ashraf A. El-Ghoneimy, Atsuto Onoda, Hazem M. Shaheen, Hiroshi Hori, Yusuke Shinkai, Yasser S. El-Sayed, Ali H. El-Far, Ken Takeda. Impact of diesel exhaust exposure on the liver of mice fed on omega-3 polyunsaturated fatty acids-deficient dietFood and Chemical Toxicology 2018; 111: 284 doi: 10.1016/j.fct.2017.11.027
57
Vian Azzu, Michele Vacca, Samuel Virtue, Michael Allison, Antonio Vidal-Puig. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver DiseaseGastroenterology 2020; 158(7): 1899 doi: 10.1053/j.gastro.2019.12.054
58
Kalliopi Pafili, Michael Roden. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humansMolecular Metabolism 2021; 50: 101122 doi: 10.1016/j.molmet.2020.101122
59
Wei-ning Jiang, Dan Li, Tao Jiang, Jiao Guo, Yan-fen Chen, Jie Wang, Yun Zhou, Chao-yan Yang, Chun-ping Tang. Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin ResistanceChinese Journal of Integrative Medicine 2018; 24(2): 125 doi: 10.1007/s11655-016-2252-4